���重受体激动剂的分子设计 — Beginner to Advanced

By Editorial Desk · published 2025-11-08 · last reviewed 2025-12-27 · Blog

If you have been reading about glucagon receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2025-12-27. Numbers and descriptions here follow the published literature rather than marketing material.

三重受体激动剂的分子设计

化学修饰延长了分子在体内的停留时间，使较低频次的给药安排成为可能。脂肪酸侧链通过与白蛋白结合延缓清除，非天然氨基酸则降低酶解速率。这些修饰同时改变分子的溶解性与稳定性，需要在制剂设计和储存条件中一并考虑。修饰引入的免疫原性风险也属于开发过程中需要评估的项目。

该化合物处于临床试验阶段，尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录，完整数据仍在逐步披露。关于长期疗效与安全性的判断，需要等待规模更大、随访更久的研究结果，目前不宜对最终结论作出预判。

retatrutide 是一种人工合成的多肽，设计目标是同时作用于 GIP、GLP-1 与胰高血糖素三种受体。这种三重激动设计试图把多条代谢通路的调节整合进单一分子，而不是只依赖一种肠促胰素受体。分子骨架以天然肽序列为基础，经过非天然氨基酸替换和脂肪酸侧链修饰，以获得更长的作用时间。该方向属于多受体激动剂研究的一部分，与双重激动剂的工作并行推进。

Molecular Identity and Receptor Targets

Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.

Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.

Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.

Retatrutide at a glance

瑞他鲁肽药理机制

临床研究通常测量体重、腰围、空腹血糖、糖化血红蛋白和血脂，并记录不良事件。药代动力学评估关注浓度-时间曲线，药效动力学评估关注代谢标志物变化。体重下降由能量摄入减少、能量消耗变化和脂肪组织重塑共同造成，具体权重仍不明确。研究之间的终点定义和随访时长差异使横向比较复杂。

瑞他鲁肽同时激活GLP-1受体、GIP受体和胰高血糖素受体，这三者均属于B类G蛋白偶联受体。受体激活后主要经cAMP信号通路传递效应。GLP-1成分与食欲抑制和胃排空延缓相关，GIP成分影响脂肪组织与胰岛素分泌，胰高血糖素成分则促进肝糖输出和能量消耗。各受体贡献的相对比例在人体中尚未完全量化。

Related pages on this site

• Standard notes
• Simple workbook
• Verified reference
• Quality playbook
• Quality review
• Automated report
• Focused trends
• Automated archive

Discovery and Triple Receptor Pharmacology

Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.

Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.

Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.

Trial Endpoints and Interpretation

Body composition is assessed with dual-energy X-ray absorptiometry or comparable methods, which separate fat mass from lean mass. Reported losses include both compartments, and the ratio between them is a subject of ongoing analysis rather than a settled result. Waist circumference, blood pressure, and lipid panels are collected as supporting measures. Resting energy expenditure and substrate oxidation are measured in smaller mechanistic studies, where glucagon receptor activity is expected to matter. These substudies are typically short and small, so their findings carry wide uncertainty.

Interpretation depends on study phase and duration. Phase 2 programs are powered for weight and safety signals, not for cardiovascular or renal outcomes, which require event-driven designs. Gastrointestinal events such as nausea, diarrhea, vomiting, and constipation are the most frequently reported adverse effects and tend to cluster around dose escalation. Small increases in heart rate have been described. Because follow-up after treatment discontinuation is limited, questions about weight regain and durability are open rather than answered.

Trial reports for this compound rely on a small set of repeated measures. Body weight is normally expressed as percent change from baseline at a fixed week, with absolute kilograms given secondarily. Glycemic endpoints include HbA1c, fasting glucose, and, in some protocols, continuous glucose monitoring summaries. Imaging endpoints such as MRI-derived proton density fat fraction quantify liver fat. Standardization matters because a percent change and a categorical responder analysis can tell different stories about the same dataset.

Further detail

Kinases act upon many other molecules besides proteins, lipids, and carbohydrates. There are many that act on nucleotides (DNA and RNA) including those involved in nucleotide interconverstion, such as nucleoside-phosphate kinases and nucleoside-diphosphate kinases. Other small molecules that are substrates of kinases include creatine, phosphoglycerate, riboflavin, dihydroxyacetone, shikimate, and many others.

CPC Scientific’s manufacturing processes primarily use solid-phase peptide synthesis (SPPS), first described by Robert Bruce Merrifield in 1963. SPPS allows peptides to be assembled stepwise on a solid support, enabling the preparation of long and complex sequences for use as active pharmaceutical ingredients (APIs), investigational drugs, and research materials. Researchers associated with the company have published studies involving peptide synthesis methodologies, including work related to hydrocarbon stapling. Products manufactured by the company have been used and cited in various scientific studies. Official website

25298Cf + 115B → 263103Lr* → 258103Lr + 5 10n The first work at Dubna on element 103 came in 1965, when they reported to have made 256Lr in 1965 by bombarding 243Am with 18O, identifying it indirectly from its granddaughter fermium-252. The half-life they reported was somewhat too high, possibly due to background events. Later 1967 work on the same reaction identified two decay energies in the ranges 8.35–8.50 MeV and 8.50–8.60 MeV: these were assigned to 256Lr and 257Lr. Despite repeat attempts, they were unable to confirm assignment of an alpha emitter with a half-life of 8 seconds to 257Lr. The Russians proposed the name "rutherfordium" for the new element in 1967; this name was later proposed by Berkeley for element 104.

== Limitations == Nasal administration is primarily suitable for potent drugs since only a limited volume can be sprayed into the nasal cavity. Drugs for continuous and frequent administration may be less suitable because of the risk of harmful long-term effects on the nasal epithelium. Nasal administration has also been associated with a high variability in the amount of drug absorbed. Upper airway infections may increase the variability as may the extent of sensory irritation of the nasal mucosa, differences in the amount of liquid spray that is swallowed and not kept in the nasal cavity and differences in the spray actuation process. However, the variability in the amount absorbed after nasal administration should be comparable to that after oral administration.

==== Road ==== The post road built by Thomas Telford from London strengthened Holyhead's position as the port from which the Royal Mail was dispatched to and from Dublin on the Mail coach. The A5 terminates at Admiralty Arch (1822–24), which was designed by Thomas Harrison to commemorate a visit by King George IV in 1821 en route to Ireland and marked the zenith of Irish Mail coach operations. Holy Island and Anglesey are separated by the Cymyran Strait which used to be crossed on the Four Mile Bridge; so called, because the bridge was 4 miles (6 kilometres) from Holyhead on the old turnpike.

Sources: en.wikipedia.org

Supporting material

== Middle Ages and Renaissance == Ferdowsi (940–1020) was a Persian poet who lived in the Abbasid Caliphate. In Shahnameh, his national epic poem, Ferdowsi described a caesarean section performed on Rudaba. A special wine prepared by a Zoroastrian priest was used as an anesthetic for this operation. Circa 1020, Ibn Sīnā (980–1037) in The Canon of Medicine described the "soporific sponge", a sponge imbued with aromatics and narcotics, which was to be placed under a patient's nose during surgical operations. Opium made its way from Asia Minor to all parts of Europe between the 10th and 13th centuries. Throughout 1200 to 1500 AD in England, a potion called dwale was used as an anesthetic. This alcohol-based mixture contained bile, opium, lettuce, bryony, henbane, hemlock, and vinegar. Surgeons roused their patients by rubbing vinegar and salt on their cheekbones. One can find records of dwale in numerous literary sources, including Shakespeare's Hamlet, and the John Keats poem "Ode to a Nightingale". In the 13th century, we have the first prescription of the "spongia soporifica"—a sponge soaked in the juices of unripe mulberry, flax, mandragora leaves, ivy, lettuce seeds, lapathum, and hemlock with hyoscyamus. After treatment and/or storage, the sponge could be heated and the vapors inhaled with anesthetic effect. Alchemist Ramon Llull has been credited with discovering diethyl ether in 1275. Philippus Aureolus Theophrastus Bombastus von Hohenheim (1493–1541), better known as Paracelsus, discovered the analgesic properties of diethyl ether around 1525.

Hardmaxxing is a subset of looksmaxxing that refers to more extreme practices in order to achieve significant changes to one's appearance and facial structure. These include off-label or unauthorized use of substances (such as anabolic steroids, peptides, human growth hormone, aromatase inhibitors, weight loss medications, etc.) to achieve a taller stature, more masculine appearance and greater muscle mass; extreme dieting to the point of starvation to achieve a low body fat level; and skin whitening to achieve a lighter skin tone, which is interpreted as being more desirable; and undergoing cosmetic surgeries, such as jaw surgery and rhinoplasty. More dubiously, a practice known as bonesmashing, which refers to the act of hitting one's face against objects such as a hammer in order to create a "chiselled look", is often described when discussing looksmaxxing. This practice is considered an inside joke and is rarely done. Sources label it as misinformation.

==== Nervous system ==== The connections between neurons, the primary cell of the nervous system, forms neural pathways, neural circuits, and large-scale brain networks. Subsystems of the human nervous system include:

The males of ancient Greece believed that small penises were ideal. Scholars believe that most ancient Greeks probably had the same size penises as other Europeans, but Greek artistic portrayals of handsome youths show them with inordinately small, uncircumcised penises with disproportionately large foreskins, indicating that these were seen as ideal. Large penises in Greek art are reserved for comically grotesque figures, such as satyrs, a class of hideous, horse-like woodland spirits, who are shown in Greek art with absurdly massive penises. Actors portraying male characters in ancient Greek comedy wore enormous, fake, red penises, which dangled underneath their costumes; these were intended as ridiculous and were meant to be laughed at. In Aristophanes's comedy The Clouds, "Mr. Good Reason" gives the character Pheidippides a description of the ideal youth: "A glistening chest and glowing skin / Broad shoulders, a small tongue /A mighty bottom and a tiny prong." In Greek mythology, Priapus, the god of fertility, had an impossibly large penis that was permanently erect. Priapus was widely seen as hideous and unattractive. A scholion on Apollonius of Rhodes's Argonautica states that when Priapus' mother Aphrodite, the goddess of love and beauty, gave birth to him, she was so horrified by the size of his penis, his massive potbelly, and his huge tongue that she abandoned him to die in the wilderness. A herdsman found him and raised him as his son, later discovering that Priapus could use his massive penis to aid in the growth of plants.

== Production == In May 2025, it was announced that Andrés Baiz would be directing his English-language debut film, with Jamie Foxx in the lead role, who plays a coach hired to reconstitute the U.S. Olympic boxing team after the original team is killed in a tragic plane crash in 1980. In October, Malachi Beasley, Shea Whigham, Dan Perrault, Will Chase, Algee Smith, Jamir Cope, Mitchell Edwards, Al-Shabazz Jabateh, Tre McBride, Xavier Mills, Adrian Martinez, and Javier Bolaños rounded out the cast.

Sources: en.wikipedia.org

Notes from published material

Silence was their way of maintaining control in these situations, but it often came at the expense of their health and the advancement of female health and medicine. This silence and control were most obviously seen when the health problem was related to the core of Ming fuke, or the sexual body. It was often in these diagnostic settings that women would choose silence. In addition, there would be a conflict between patient and doctor on the probability of her diagnosis. For example, a woman who thought herself to be past the point of child-bearing age, might not believe a doctor who diagnoses her as pregnant. This only resulted in more conflict.

=== Legal categorization and legal issues in a near future === Currently, siRNAs are chemically synthesized and are therefore legally categorized in the EU and the US as simple medicinal products. But as bioengineered siRNA (BERAs) are in development, these would be classified as biological medicinal products, at least in the EU. The development of the BERAs technology raises the question of the categorization of drugs having the same mechanism of action but being produced chemically or biologically. This lack of consistency should be addressed.

But creating a type of airplane named AIRPLANE doesn't make you Wilbur Wright." Thomas Haigh, a historian of information technology at the University of Wisconsin–Milwaukee, wrote that "Ayyadurai is, to the best of my knowledge, the only person to have claimed for him or herself the title 'inventor of email'." Haigh argued that while EMAIL was impressive for a teenager's work, it contained no features that were not present on previous electronic mail systems and had no obvious influence on later systems. "The most striking thing about Ayyadurai's claim to have invented electronic mail is how late it comes. Somehow it took him thirty years to alert the world to [his] greatest achievement". Haigh wrote that by 1980, "electronic mail had been in use at MIT for 15 years, Xerox had built a modern, mouse-driven graphical email system for office communication, Compuserve was selling email access to the public, and email had for many years been the most popular application on what was soon to become the Internet." Haigh wrote that Ayyadurai had created "infographic" outlines for his view of history and published the assembled documents under various domain names that he had registered to support his claim. Through his infographics, wrote Haigh, Ayyadurai presented his claims that he "designed and deployed the first version of electronic [mail] system" in 1980, although electronic mail as an executable program was used under the name "Electronic Mail System" before.

The industry was also affected by disputes about whether grain or blended whisky was worthy of the name, with an adverse decision in North London Police Court in 1905. A Royal Commission on Whisky and other Potable Spirits was appointed in 1906 and reported in 1909 with a victory for the grain distillers and blenders. The industry was further affected by World War I, Prohibition in the United States and later, by the Great Depression; many of the companies closed and never re-opened. Of the 159 distilleries operating in the boom years around 1900, only 15 survived to 1933. During the 1970s there was a new boom in Scotch whisky production that led to an overproduction in the early 1980s. Starting in 1981 whisky distilleries slashed production by a third and kept it low for a decade. During that time many distilleries closed. Banff, Brora, Coleburn, Convalmore, Dallas Dhu, Glen Albyn, Glenesk, Glen Flagler, Glenlochy, Glen Mhor, Glenugie, Glenury, Millburn, North Port, Port Ellen and St Magdalene were mothballed, shut down or demolished. Since the 2010s, Scotch whisky has entered a new phase of growth with new distilleries like Ardnahoe and Borders opening and older distilleries like Brora, Port Ellen and Rosebank reopening.

Science and Industry 2 - It was released on July 3, 2008 as a sequel to the GoldSrc mod. The gameplay is similar to the previous mod where the main objective is to capture enemy NPC scientists while defending your own. Synergy - A cooperative mod. Synergy supports official campaigns by Valve, user-made levels, and other third-party mods (MINERVA, City 7, and Riot Act). In September 2008, Valve introduced it as one of the first five Source mods being offered on Steam and supported by Steamworks. Team Fortress 2 Classified - A Team Fortress 2 mod that reimagines the game using its 2008-2009 incarnation as a base, adding new weapons, maps, and game modes. Zombie Panic! Source - A team-based zombie themed mod which pits player-controlled survivors against player-controlled zombies. The gameplay style simulates an outbreak: The zombie team starts with only a few players, but their ranks grow as survivors are defeated and switch to the zombie team. Its first public release was on December 28, 2007, and it received the Mod DB, players' choice, top unreleased mod award for 2007.

Sources: en.wikipedia.org

Frequently asked questions